188 related articles for article (PubMed ID: 32848410)
1. The Combination of Plasma Fibrinogen Concentration and Neutrophil Lymphocyte Ratio (F-NLR) as a Prognostic Factor of Epithelial Ovarian Cancer.
Yang J; Ma J; Cheng S; Wang Y
Onco Targets Ther; 2020; 13():7283-7293. PubMed ID: 32848410
[TBL] [Abstract][Full Text] [Related]
2. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.
Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L
J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer.
Huang W; Wang S; Zhang H; Zhang B; Wang C
Cancer Biol Med; 2018 Feb; 15(1):88-96. PubMed ID: 29545972
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study.
Kong W; Xu H; Cheng J; Fang Z; Wang H; Zhang J; Wang X; Dai T; Gao Y
Med Sci Monit; 2020 Jan; 26():e918824. PubMed ID: 31929496
[TBL] [Abstract][Full Text] [Related]
5. Combination of Preoperative Plasma Fibrinogen and Neutrophil-to-Lymphocyte Ratio (the F-NLR Score) as a Prognostic Marker of Locally Advanced Rectal Cancer Following Preoperative Chemoradiotherapy.
Sun Y; Zhang Y; Huang Z; Lin H; Lu X; Huang Y; Chi P
World J Surg; 2020 Jun; 44(6):1975-1984. PubMed ID: 32020327
[TBL] [Abstract][Full Text] [Related]
6. Combined fibrinogen and neutrophil-lymphocyte ratio as a predictive factor in resectable colorectal adenocarcinoma.
Li X; An B; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
Cancer Manag Res; 2018; 10():6285-6294. PubMed ID: 30568490
[TBL] [Abstract][Full Text] [Related]
7. Combination of preoperative fibrinogen concentration and neutrophil-to-lymphocyte ratio for prediction of the prognosis of patients with resectable breast cancer.
Cao X; Zhou Y; Mao F; Lin Y; Sun Q
Oncol Lett; 2020 Nov; 20(5):200. PubMed ID: 32963606
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the combination of preoperative fibrinogen and the neutrophil-lymphocyte ratio in patients with non-small cell lung cancer following surgical resection.
Liang HG; Gao K; Jia R; Li J; Wang C
Oncol Lett; 2019 Feb; 17(2):1435-1444. PubMed ID: 30675197
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer.
Iwasaki M; Ishihara S; Okada S; Shimegi R; Shimomura M; Inoue M
Ann Surg Oncol; 2022 Sep; 29(9):5699-5707. PubMed ID: 35653068
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment Neutrophil-to-Lymphocyte Ratio: A Prognostic Biomarker of Survival in Patients With Epithelial Ovarian Cancer.
John-Olabode SO; Okunade KS; Olorunfemi G; Soibi-Harry A; Rimi G; Osunwusi B; Okunowo A; Amaeshi L; Anorlu R
Cureus; 2021 Jul; 13(7):e16429. PubMed ID: 34422466
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of the Combined Index of Plasma Fibrinogen and the Neutrophil-Lymphocyte Ratio in Gastric Cancer.
Yamamoto M; Kurokawa Y; Kobayashi N; Takahashi T; Miyazaki Y; Tanaka K; Makino T; Yamasaki M; Nakajima K; Mori M; Doki Y
World J Surg; 2020 Jan; 44(1):207-212. PubMed ID: 31559484
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of FA score based on plasma fibrinogen and serum albumin in patients with epithelial ovarian cancer.
Li Y; Yang JN; Cheng SS; Wang Y
Cancer Manag Res; 2019; 11():7697-7705. PubMed ID: 31616185
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-to-Lymphocyte Ratio and Platelet Count Predict Long-Term Outcome of Stage IIIC Epithelial Ovarian Cancer.
Zhou M; Li L; Wang X; Wang C; Wang D
Cell Physiol Biochem; 2018; 46(1):178-186. PubMed ID: 29587273
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic significance of combined plasma fibrinogen concentrations and the monocyte-to-lymphocyte ratio in patients with ovarian cancer.
Cao Y; Ni X; Wang Y; Wang L; Yuan K; Gan G; Zhang K; Zhao Z; Fei X
Ann Transl Med; 2019 Jun; 7(11):242. PubMed ID: 31317012
[TBL] [Abstract][Full Text] [Related]
15. The Ratio of Neutrophil to Lymphocyte is a Predictor in Endometrial Cancer.
Dong Y; Cheng Y; Wang J
Open Life Sci; 2019 Jan; 14():110-118. PubMed ID: 33817142
[TBL] [Abstract][Full Text] [Related]
16. The combination of preoperative fibrinogen and neutrophil-lymphocyte ratio is a predictive prognostic factor in esophagogastric junction and upper gastric cancer.
Cong X; Li S; Zhang Y; Zhu Z; Wang Y; Song S; Ma Y; Xie R; Xue Y
J Cancer; 2019; 10(22):5518-5526. PubMed ID: 31632495
[No Abstract] [Full Text] [Related]
17. Prognostic analysis of the plasma fibrinogen combined with neutrophil-to-lymphocyte ratio in patients with non-small cell lung cancer after radical resection.
Wang GX; Huang ZN; Ye YQ; Tao SM; Xu MQ; Zhang M; Xie MR
Thorac Cancer; 2023 May; 14(15):1383-1391. PubMed ID: 37037492
[TBL] [Abstract][Full Text] [Related]
18. Combination of preoperative plasma fibrinogen and neutrophil-to-lymphocyte ratio to predict the prognosis for patients undergoing laparoscopic nephrectomy for renal cell carcinoma.
Ni J; Wang Y; Zhang H; Wang K; Song W; Luo M; Che J; Geng J; Xu Y; Yao X; Zheng J; Chen M; Peng B; Mao W
Am J Cancer Res; 2022; 12(8):3713-3728. PubMed ID: 36119818
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the Fibrinogen and Neutrophil-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis.
Arigami T; Okumura H; Matsumoto M; Uchikado Y; Uenosono Y; Kita Y; Owaki T; Mori S; Kurahara H; Kijima Y; Ishigami S; Natsugoe S
Medicine (Baltimore); 2015 Oct; 94(42):e1702. PubMed ID: 26496280
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
Miao Y; Yan Q; Li S; Li B; Feng Y
Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
